Relation of 12-Lead Electrocardiogram Patterns to Implanted Defibrillator-Terminated Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 104, Issue 12, 2009, Pages 1722-1726

  Sherrid, Mark V ^a   Cotiga, Delia ^a   Hart, David ^k   Ehlert, Frederick ^b   Haas, Tammy S ^d   Shen, Win Kuang ^e   Link, Mark S ^f   Estes III, N A Mark ^f   Epstein, Andrew E ^g   Semsarian, Christopher ^h   Daubert, James P ^c   Winters, Stephen L ⁱ   Giudici, Michael C ^j   Maron, Barry J ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e MAYO CLINIC   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ MORRISTOWN MEMORIAL HOSPITAL   (United States)

^j Genesis Heart Institute   (United States)

^k THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DEFIBRILLATOR; ECG ABNORMALITY; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; QT DISPERSION; RISK ASSESSMENT; SUDDEN DEATH;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 70749120430     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.056     Document Type: Article

References (20)

1. Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., Boriani G., Estes III N.A., Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S., Arribas F., Sherrid M.V., Buja G., Semsarian C., and Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
2. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer III W.H., Spirito P., Ten Cate F.J., and Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
3. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., and McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
4. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
5. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
6. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
7. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., and McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42 (2003) 873-879
8. Maron B.J., Wolfson J.K., Ciro E., and Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 51 (1983) 189-194
9. Montgomery J.V., Harris K.M., Casey S.A., Zenovich A.G., and Maron B.J. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96 (2005) 270-275
10. Dumont C.A., Monserrat L., Soler R., Rodriguez E., Fernandez X., Peteiro J., Bouzas A., Bouzas B., and Castro-Beiras A. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 27 (2006) 1725-1731
11. Koga Y., Yamaga A., Hiyamuta K., Ikeda H., and Toshima H. Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol 15 (2004) 1402-1408
12. Maron B.J., and Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
13. Almquist A.K., Montgomery J.V., Haas T.S., and Maron B.J. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2 (2005) 814-819
14. Boriani G., Maron B.J., Shen W.K., and Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient?. Circulation 110 (2004) e438-e442
15. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., Estes III N.A., and Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
16. Cha Y.M., Gersh B.J., Maron B.J., Boriani G., Spirito P., Hodge D.O., Weivoda P.L., Trusty J.M., Friedman P.A., Hammill S.C., Rea R.F., and Shen W.K. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 18 (2007) 483-487
17. McLeod C.J., Ackerman M.J., Nishimura R.A., Tajik A.J., Gersh B.J., and Ommen S.R. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol 54 (2009) 229-233
18. Bongioanni S., Bianchi F., Migliardi A., Gnavi R., Pron P.G., Casetta M., and Conte M.R. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol 100 (2007) 503-506
19. Yi G., Poloniecki J., Dickie S., Elliott P.M., Milik M., and McKenna W.J. Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy?. Ann Noninvasive Electrocardiol 6 (2001) 209-215
20. Maron B.J., Leyhe III M.J., Casey S.A., Gohman T.E., Lawler C.M., Crow R.S., Maron M.S., and Hodges M. Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. Am J Cardiol 87 (2001) 114-115